A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma

Detalles Bibliográficos
Autores principales: Papayannidis, C, DeAngelo, D J, Stock, W, Huang, B, Shaik, M N, Cesari, R, Zheng, X, Reynolds, J M, English, P A, Ozeck, M, Aster, J C, Kuo, F, Huang, D, Lira, P D, McLachlan, K R, Kern, K A, Garcia-Manero, G, Martinelli, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648526/
https://www.ncbi.nlm.nih.gov/pubmed/26407235
http://dx.doi.org/10.1038/bcj.2015.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648526/
https://www.ncbi.nlm.nih.gov/pubmed/26407235
http://dx.doi.org/10.1038/bcj.2015.80

Ejemplares similares